Introduction

This Modern Slavery and Human Trafficking Statement is made pursuant to Section 54(1),

Part 6 of the UK Modern Slavery Act 2015. It sets out the steps Genmed.me Limited

(“Genmed”, “we”, “us”, or “our”)has taken during the financial year ending 30 September 2025 to prevent modern slavery and human trafficking within our business operations and supply chains.

Genmed maintains a zero-tolerance approach to all forms of modern slavery, including slavery, servitude, forced or compulsory labour, and human trafficking. Our Group Chief Executive Officer (CEO) is responsible for oversight of our approach to identifying, assessing, and managing modern slavery risk.

Our Organisation

Genmed.me Limited operates within the UK healthcare sector, providing managed service solutions that support operational and financial efficiency for clinical teams.

We manage procurement activities, supplier rationalisation, implementation of inventory control systems, and tendering processes that help NHS and private healthcare partners reduce costs and administrative burden.

Further information about our services is available at: www.Genmed.eu

Our Supply Chain

Our supply chain includes a wide range of medical equipment suppliers, consumables providers, logistics partners, and service-related contractors. While our direct supply chain is primarily based in the UK, some products may originate from global supply chains. -related contractors. While our direct supply chain is primarily based in the UK, some products may originate from global supply chains.

We acknowledge that visibility beyond Tier 1 suppliers can be limited, and we are committed to improving transparency in future years.

Our Position on Modern Slavery

Genmed recognises that modern slavery can occur in many forms, including forced labour, servitude, domestic servitude, human trafficking, and workplace exploitation.

We act ethically and with integrity in all business dealings, ensuring systems and controls are in place to safeguard against any form of modern slavery.

We expect all suppliers, contractors, and partners to up hold the same high standards.

Assessing & Managing Risk

During the year, we assessed our exposure to modern slavery risk by:

Reviewing risks associated with new suppliers during onboarding.
Conducting ad hoc reviews of existing suppliers based on supply chain mapping.
Evaluating whether any categories of procurement fall into recognised high-risk sectors.
We do not consider that Genmed currently operates in a high-risk environment. However, we remain vigilant and will continue strengthening our due diligence processes. -risk environment. However, we remain vigilant and will continue strengthening our due diligence processes.

Due Diligence

We undertake the following due diligence activities:

Requiring suppliers to confirm compliance with the Modern Slavery Act or relevant international legislation.
Assessing supplier policies, including anti-slavery measures and labour standards. Ensuring UK suppliers pay at least the National Minimum Wage/National Living Wage.
Requiring international suppliers to meet minimum prevailing wages in their jurisdiction.
Removing any supplier from our preferred list if they fail to meet our standards. Where a supplier cannot demonstrate adequate controls to prevent modern slavery, we may suspend or terminate the relationship.

Training

All employees must complete mandatory modern slavery training every 12 months through our online learning portal. Training covers:

identifying signs of slavery and human trafficking
initial action to take if concerns arise
escalation routes within the business
available external support
steps to take when suppliers do not meet expected standards This ensures our staff understand the risks and their responsibilities.

Relevant Internal Policies

We maintain several internal policies that support our commitment to preventing modern slavery:

Anti-Slavery and Human Trafficking Policy
Recruitment Policy (including right to work checks and direct communication with candidates) -to-work checks and direct communication with candidates)
Whistle blowing Policy (employees can raise concerns safely and confidentially)
Code of Conduct (setting expected standards for employees and suppliers)
These policies are updated regularly to reflect best practice and legislative requirements.

Actions Taken in 2024–25

During this reporting period, Genmed:

Ensured all approved suppliers confirmed compliance with the Modern Slavery Act 2015 or equivalent legislation.
Provided training for employees responsible for supply chain management.
Required suppliers to confirm they pay at least the Real Living Wage where applicable.
Completed awareness training for all employees and identified no high-risk contracting areas requiring further action, risk contracting areas requiring further action.
No incidents of modern slavery or human trafficking were identified within our operations or supply chain.

Performance Indicators

We monitor the effectiveness of our approach through:

Supplier confirmations of compliance at regular intervals.
Training completion rates for all employees.
Absence of reported modern slavery concerns from employees, the public, or law enforcement.
Genmed has not identified any suppliers or operational areas presenting significant risk during the reporting year.

Future Commitments(2025–26)

For the forthcoming financial year, Genmed will:

Continue strengthening training and awareness for all employees.
Enhance supplier monitoring and request additional evidence of due diligence.
Refine our supply chain mapping to identify potential high-risk areas. -risk areas.
Review updated guidance and best practice in modern slavery compliance.
Conduct a refreshed modern slavery risk assessment.

These actions ensure we remain vigilant and continuously improve our approach.